Conference Call with Galaxy Surfactants Management and Analysts on Q2FY25 Performance and Outlook. Listen to the full earnings transcript.
Specialty Chemicals company Galaxy Surfactants announced Q2FY25 results Total Revenue: Rs 1,071.7 crore compared to Rs 985.8 crore during Q2FY24, change 8.7%. EBITDA: Rs 136.3 crore compared to Rs 127.6 crore during Q2FY24, change 6.9%. EBITDA Margin: 12.7% for Q2FY25. PAT: Rs 84.7 crore compared to Rs 77.4 crore during Q2FY24, change 9.4%. PAT margin: 7.9% for Q2FY25. K. Natarajan, Managing Director, Galaxy Surfactants, said: “Q2FY25 was a mixed quarter for us. While this Quarter has seen sequential Volume growth as well as YoY mid single digit volume growth driven primarily by our Specialty Care products; a slowdown in India remains an area of concern. The significant uptick in raw material prices combined with supply chain challenges did disturb momentum in this quarter and remains a major risk going ahead. While EBITDA/MT came in below the guided band of Rs 20,500-21,500 at 20,097/MT; improvement in premium specialties business should aid margins going ahead. We strongly believe, the sequential improvement seen in this quarter, is a major positive and the same should continue going ahead.” Result PDF